Episode 153: Good News in a COVID-Indifferent World

Osterholm Update

CIDRAP

Science

4.8 • 2.9K Ratings

🗓️ 21 March 2024

⏱️ 71 minutes

🔗️ Recording | iTunes | RSS

🧾️ Download transcript

Summary

In "Good News in a COVID-Indifferent World," Dr. Osterholm and Chris Dall discuss the national and international COVID trends, the latest research on long COVID, and antibiotic-resistant Shigella. Dr. Osterholm also shares the latest "This Week in Public Health History" segment and interviews members of the podcast team.

Iron dysregulation and inflammatory stress erythropoiesis associates with long-term outcome of COVID-19 (Hanson et al., Nature Immunology)
How Americans view the coronavirus, COVID-19 vaccines amid declining levels of concern (Tyson & Pasquini, Pew Research Center)
Spike in extensively drug-resistant Shigella cases reported in UK, Europe (Dall, CIDRAP News)
CDC warns of increase in extensively drug-resistant shigellosis (Dall, CIDRAP News)
Superbugs & You podcast — new episode coming 3/26!
The man in the iron lung (McRobbie, The Guardian)
More episodes
Support this podcast

Transcript

Click on a timestamp to play from that location

0:00.0	Hello and welcome to the Osterholm update, a podcast on COVID-19 and other infectious diseases with Dr Michael Osterholm.
0:15.0	Dr Ostrom is an internationally recognized medical detective and director of the Center for
0:20.3	Infectious Disease Research and Policy or or Sidrapp at the University of Minnesota.
0:25.2	In this podcast, Dr. Ostrom draws on nearly 50 years of experience investigating
0:29.6	infectious disease outbreaks to provide straight talk on the latest infectious disease
0:33.7	and public health threats.
0:36.0	I'm Chris Dahl, reporter for Sidrapp News,
0:38.8	and I'm your host for these conversations.
0:44.0	Welcome back everyone to another episode of the Osterome Update Podcast.
0:48.0	Last week, the National Institutes of Health announced the launch of two Phase two clinical trials to test the safety and
0:54.4	efficacy of three treatments for long COVID patients who have experienced symptoms such
0:58.7	as fast heart rate, dizziness, and fatigue. The trials are among several efforts aimed at long COVID,
1:05.2	understanding what causes it, how to best treat symptoms, and how to test for it.
1:10.6	On this March 21st episode of the podcast, we're going to spend some time talking about
1:15.1	those efforts and what some of the latest research on long COVID tells us after we examine
1:19.9	the latest data on COVID-19 here in the United States and elsewhere.
1:23.2	We'll also discuss a recent survey on how Americans are feeling about COVID-19,
1:28.2	look at the latest flu and RSV data, discuss the latest measles outbreak, and examine the emergence of antibiotic resistant
1:35.6	shigella.
1:36.6	We'll also bring you the latest installment of this week in public health history, and our first
1:40.9	segment marking the four-year anniversary of the podcast.
1:44.0	But before we get started, we'll begin with Dr. Ostrom's opening comments and dedication.
	...

Please login to see the full transcript.

Previous episode | Next episode

Disclaimer: The podcast and artwork embedded on this page are from CIDRAP, and are the property of its owner and not affiliated with or endorsed by Tapesearch.

Generated transcripts are the property of CIDRAP and are distributed freely under the Fair Use doctrine. Transcripts generated by Tapesearch are not guaranteed to be accurate.